ConductScience.org, home

Paper34734802

Molecular features underlying differential SHP1/SHP2 binding of immune checkpoint receptors.

Xu X and 4 others. Elife, 2021. Cited by 61 papers, by iCite.

Cite this record

ConductScience Library. Molecular features underlying differential SHP1/SHP2 binding of immune checkpoint receptors. Papers, record 34734802. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/34734802

Download JSON
Cell line
HEK293T2,726 papers
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Molecular features underlying differential SHP1/SHP2 binding of immune checkpoint receptors.
PubMed
Journal
Elife
PubMed
Year
2021
PubMed
Publication types
Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
61
iCite
Relative citation ratio, by iCite
3.18
iCite
Revised in PubMed
2021-12-14
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Programmed Cell Death 1 ReceptorMajor topic
Protein Tyrosine Phosphatase, Non-Receptor Type 6Major topic
Receptors, ImmunologicMajor topic
src Homology DomainsMajor topic
Cell Communication
Cell Line, Tumor
Gene Knockout Techniques
HEK293 Cells
Humans
Jurkat Cells
Recombinant Proteins
Signal Transduction
T-Lymphocytes

Source PubMed

Download CSV of topics

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
R37 CA239072NCI NIH HHSUnited StatesR37CA239072PubMed and NIH

Source NIH RePORTER

Download CSV of grants

References56

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
119290938SHP-1 and SHP-2 in T cells: two phosphatases functioning at many levels.Immunol Rev2009https://conductscience.org/library/papers/19290938PubMed
218518340Statistical thermodynamics of the stability of multivalent ligand-receptor complexes.Phys Rev Lett2008https://conductscience.org/library/papers/18518340PubMed
321219180SLAM family receptors and SAP adaptors in immunity.Annu Rev Immunol2011https://conductscience.org/library/papers/21219180PubMed
49388260The protein-tyrosine phosphatase SHP-2 associates with tyrosine-phosphorylated adhesion molecule PECAM-1 (CD31).J Biol Chem1997https://conductscience.org/library/papers/9388260PubMed
528378014Biophysical assay for tethered signaling reactions reveals tether-controlled activity for the phosphatase SHP-1.Sci Adv2017https://conductscience.org/library/papers/28378014PubMed
627362227Allosteric inhibition of SHP2 phosphatase inhibits cancers driven by receptor tyrosine kinases.Nature2016https://conductscience.org/library/papers/27362227PubMed
714652006Characterization of phosphotyrosine binding motifs in the cytoplasmic domain of B and T lymphocyte attenuator required for association with protein tyrosine phosphatases SHP-1 and SHP-2.Biochem Biophys Res Commun2003https://conductscience.org/library/papers/14652006PubMed
89491886Crystal structure of the tyrosine phosphatase SHP-2.Cell1998https://conductscience.org/library/papers/9491886PubMed
917646384Deletion of Shp2 in the brain leads to defective proliferation and differentiation in neural stem cells and early postnatal lethality.Mol Cell Biol2007https://conductscience.org/library/papers/17646384PubMed
1032184441Interaction of SHP-2 SH2 domains with PD-1 ITSM induces PD-1 dimerization and SHP-2 activation.Commun Biol2020https://conductscience.org/library/papers/32184441PubMed
119818190Protein tyrosine phosphatases: mechanisms of catalysis and regulation.Curr Opin Chem Biol1998https://conductscience.org/library/papers/9818190PubMed
1233781765Determination of the molecular reach of the protein tyrosine phosphatase SHP-1.Biophys J2021https://conductscience.org/library/papers/33781765PubMed
1317380156Siglecs and their roles in the immune system.Nat Rev Immunol2007https://conductscience.org/library/papers/17380156PubMed
1429126798CD4+ T Cell Help Confers a Cytotoxic T Cell Effector Program Including Coinhibitory Receptor Downregulation and Increased Tissue Invasiveness.Immunity2017https://conductscience.org/library/papers/29126798PubMed
1515549731IREM-1 is a novel inhibitory receptor expressed by myeloid cells.Eur J Immunol2004https://conductscience.org/library/papers/15549731PubMed
1619426218PD-1 signaling in primary T cells.Immunol Rev2009https://conductscience.org/library/papers/19426218PubMed
1731543263The Influence of Molecular Reach and Diffusivity on the Efficacy of Membrane-Confined Reactions.Biophys J2019https://conductscience.org/library/papers/31543263PubMed
183025655A noncatalytic domain conserved among cytoplasmic protein-tyrosine kinases modifies the kinase function and transforming activity of Fujinami sarcoma virus P130gag-fps.Mol Cell Biol1986https://conductscience.org/library/papers/3025655PubMed
1912482860Crystal structure of human protein-tyrosine phosphatase SHP-1.J Biol Chem2003https://conductscience.org/library/papers/12482860PubMed
2031204070The HVEM-BTLA Axis Restrains T Cell Help to Germinal Center B Cells and Functions as a Cell-Extrinsic Suppressor in Lymphomagenesis.Immunity2019https://conductscience.org/library/papers/31204070PubMed

See all 56 referencesDownload CSV of references

Cited by50

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 61 citations.

PMIDTitleJournalYearIn PapersSource
42749259Structure-informed theoretical modeling defines principles governing avidity in bivalent protein interactions.J Biol Chem2026https://conductscience.org/library/papers/42749259PubMed
42730022Inhibitory immune checkpoints in preeclampsia: current landscape, mechanisms, and clinical perspectives.Front Immunol2026https://conductscience.org/library/papers/42730022PubMed
42638743The BTLA/HVEM axis as a key regulator for stratified functional cure in chronic hepatitis B.Front Immunol2026https://conductscience.org/library/papers/42638743PubMed
42582396Bacterial EPIYA/EPIYA-like effector motifs and host regulatory pY-SH2 logic: a sequence-informed three-layer convergence model.Front Cell Infect Microbiol2026https://conductscience.org/library/papers/42582396PubMed
42514276Beyond Hemostasis: Platelets' Multifaceted Functions in Immune Responses.Life (Basel)2026https://conductscience.org/library/papers/42514276PubMed
42245657PTPN6/SHP-1 in autoimmune disease: immune tolerance, regulatory mechanisms, and therapeutic targeting.Front Immunol2026https://conductscience.org/library/papers/42245657PubMed
42121817Ancestral BG1 Alleles and Structural Conservation Ensure Immune-Related Genetic Resilience in Southeast Asian Chicken Lineages.Animals (Basel)2026https://conductscience.org/library/papers/42121817PubMed
42074260Targeting the pMHC-TCR Interaction: Molecular Strategies and Therapeutic Potential in Autoimmunity.Int J Mol Sci2026https://conductscience.org/library/papers/42074260PubMed
41959162PD1-induced Shp2 condensation organizes inhibitory signalosomes through selective substrate partitioning.bioRxiv2026https://conductscience.org/library/papers/41959162PubMed
41867803Cancer-Causing Mutations Alter the Interplay Between Loop Dynamics and Catalysis in the Protein Tyrosine Phosphatases SHP-1 and SHP-2.bioRxiv2026https://conductscience.org/library/papers/41867803PubMed
41798064Screening of tyrosine phosphatase SHP2 (PTPN11) inhibitors from natural products with therapeutic potential for receptor tyrosine kinase-driven cancer.J Pharm Anal2026https://conductscience.org/library/papers/41798064PubMed
41507351PD-1 suppresses CAR signaling by forming the inhibitory signalosome colocalizing to CAR microclusters.Commun Biol2026https://conductscience.org/library/papers/41507351PubMed
41479885Beyond monoclonal antibodies: constraints and the case for alternative PD-1/PD-L1-targeting formats.Front Immunol2025https://conductscience.org/library/papers/41479885PubMed
41471273BTLA: An Emerging Immune Checkpoint Target in Cancer Immunotherapy.Pharmaceuticals (Basel)2025https://conductscience.org/library/papers/41471273PubMed
41079643Immune Surveillance and Immune Escape in Cancer: Mechanisms and Immunotherapy.MedComm (2020)2025https://conductscience.org/library/papers/41079643PubMed
40891582The Expanding Role of ILC2s in Allergic Airways Disease.Allergy2026https://conductscience.org/library/papers/40891582PubMed
40667828The Tumour Glyco-Code: Sialylation as a Mediator of Stromal Cell Immunosuppression in the Tumour Microenvironment.Eur J Immunol2025https://conductscience.org/library/papers/40667828PubMed
40658856T lymphocyte-specific deletion of SHP1 and SHP2 promotes activation-induced cell death of CD4+ T cells and impairs antitumor response.Proc Natl Acad Sci U S A2025https://conductscience.org/library/papers/40658856PubMed
40503235PD-1 is conserved from sharks to humans: new insights into PD-1, PD-L1, PD-L2, and SHP-2 evolution.Front Immunol2025https://conductscience.org/library/papers/40503235PubMed
40332725TIM-3 teams up with PD-1 in cancer immunotherapy: mechanisms and perspectives.Mol Biomed2025https://conductscience.org/library/papers/40332725PubMed

See all 50 cited byDownload CSV of cited by

Genes23

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
BTLA151888PubTator's text mininghttps://conductscience.org/library/genes/151888NCBI Gene
CD27429126PubTator's text mininghttps://conductscience.org/library/genes/29126NCBI Gene
CD300LF146722PubTator's text mininghttps://conductscience.org/library/genes/146722NCBI Gene
CD3E916PubTator's text mininghttps://conductscience.org/library/genes/916NCBI Gene
CD848832PubTator's text mininghttps://conductscience.org/library/genes/8832NCBI Gene
CSH21443PubTator's text mininghttps://conductscience.org/library/genes/1443NCBI Gene
GAPDH2597PubTator's text mininghttps://conductscience.org/library/genes/2597NCBI Gene
ICAM13383PubTator's text mininghttps://conductscience.org/library/genes/3383NCBI Gene
IL23558PubTator's text mininghttps://conductscience.org/library/genes/3558NCBI Gene
KLRA1P10748PubTator's text mininghttps://conductscience.org/library/genes/10748NCBI Gene
NR0B28431PubTator's text mininghttps://conductscience.org/library/genes/8431NCBI Gene
PDCD15133PubTator's text mininghttps://conductscience.org/library/genes/5133NCBI Gene
PECAM15175PubTator's text mininghttps://conductscience.org/library/genes/5175NCBI Gene
PTPN115781PubTator's text mininghttps://conductscience.org/library/genes/5781NCBI Gene
PTPN65777PubTator's text mininghttps://conductscience.org/library/genes/5777NCBI Gene
SH2D1A4068PubTator's text mininghttps://conductscience.org/library/genes/4068NCBI Gene
SIGLEC6946PubTator's text mininghttps://conductscience.org/library/genes/946NCBI Gene
SIGLEC927180PubTator's text mininghttps://conductscience.org/library/genes/27180NCBI Gene
THNSL255258PubTator's text mininghttps://conductscience.org/library/genes/55258NCBI Gene
TNFRSF148764PubTator's text mininghttps://conductscience.org/library/genes/8764NCBI Gene

See all 23 genesDownload CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/34734802

GET https://conductscience.org/api/papers/v1/34734802/references?page=2